Literature DB >> 22269104

Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins.

P Sirvent1, O Fabre, S Bordenave, D Hillaire-Buys, E Raynaud De Mauverger, A Lacampagne, J Mercier.   

Abstract

The most common and problematic side effect of statins is myopathy. To date, the patho-physiological mechanisms of statin myotoxicity are still not clearly understood. In previous studies, we showed that acute application in vitro of simvastatin caused impairment of mitochondrial function and dysfunction of calcium homeostasis in human and rat healthy muscle samples. We thus evaluated in the present study, mitochondrial function and calcium signaling in muscles of patients treated with statins, who present or not muscle symptoms, by oxygraphy and recording of calcium sparks, respectively. Patients treated with statins showed impairment of mitochondrial respiration that involved mainly the complex I of the respiratory chain and altered frequency and amplitude of calcium sparks. The muscle problems observed in statin-treated patients appear thus to be related to impairment of mitochondrial function and muscle calcium homeostasis, confirming the results we previously reported in vitro. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22269104     DOI: 10.1016/j.taap.2012.01.008

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  33 in total

Review 1.  Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?

Authors:  Dick C Chan; Jing Pang; Gerald F Watts
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

2.  Effects of fluvastatin and coenzyme Q10 on skeletal muscle in normo- and hypercholesterolaemic rats.

Authors:  J Vincze; Á Jenes; M Füzi; J Almássy; R Németh; G Szigeti; B Dienes; Z Gaál; P Szentesi; I Jóna; P Kertai; G Paragh; L Csernoch
Journal:  J Muscle Res Cell Motil       Date:  2015-04-29       Impact factor: 2.698

3.  Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study.

Authors:  Emmanuel Barrat; Yassine Zaïr; Pascal Sirvent; Patrice Chauveau; Corinne Maudet; Béatrice Housez; Elodie Derbord; Jean-François Lescuyer; Jean-Marie Bard; Murielle Cazaubiel; Sébastien L Peltier
Journal:  Eur J Nutr       Date:  2012-12-25       Impact factor: 5.614

Review 4.  The effects of statin medications on aerobic exercise capacity and training adaptations.

Authors:  Zsolt Murlasits; Zsolt Radák
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

5.  Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy.

Authors:  Manish Suneja; Daniel K Fox; Brian D Fink; Judy A Herlein; Christopher M Adams; William I Sivitz
Journal:  Transl Res       Date:  2015-01-28       Impact factor: 7.012

6.  The UPRmt Protects Caenorhabditis elegans from Mitochondrial Dysfunction by Upregulating Specific Enzymes of the Mevalonate Pathway.

Authors:  Olga Oks; Shany Lewin; Irina Langier Goncalves; Amir Sapir
Journal:  Genetics       Date:  2018-03-29       Impact factor: 4.562

7.  The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study.

Authors:  Magnus Asping; Nis Stride; Ditte Søgaard; Tine Lovsø Dohlmann; Jørn W Helge; Flemming Dela; Steen Larsen
Journal:  Eur J Clin Pharmacol       Date:  2017-02-28       Impact factor: 2.953

8.  The Effect of Atorvastatin on Habitual Physical Activity among Healthy Adults.

Authors:  Gregory A Panza; Beth A Taylor; Paul D Thompson; Liv Erhard; Jeffrey A Capizzi; Adam S Grimaldi; Stephanie M Cole; Stuart Chipkin; Justin Keadle; C Michael White; Linda S Pescatello
Journal:  Med Sci Sports Exerc       Date:  2016-01       Impact factor: 5.411

9.  Simvastatin impairs exercise training adaptations.

Authors:  Catherine R Mikus; Leryn J Boyle; Sarah J Borengasser; Douglas J Oberlin; Scott P Naples; Justin Fletcher; Grace M Meers; Meghan Ruebel; M Harold Laughlin; Kevin C Dellsperger; Paul J Fadel; John P Thyfault
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

Review 10.  Statin use in prediabetic patients: rationale and results to date.

Authors:  Anastazia Kei; Evangelos C Rizos; Moses Elisaf
Journal:  Ther Adv Chronic Dis       Date:  2015-09       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.